Swift Outpatient Alternatives for Rapid Stabilization (SOARS) for Suicidal Youth

This study, called SOARS, is looking for young people aged 13 to 21 who are experiencing suicidal thoughts or have recently attempted suicide. It aims to find the best combination of behavioral therapies to help reduce these thoughts and behaviors. All participants will receive a 90-minute session of CAMS (Collaborative Assessment and Management of Suicidality) and care navigation. You might also receive additional support like coping skills training for yourself, skills training for your parents or caregivers, and strategies for lethal means safety (reducing access to things that could be used for harm). Researchers will measure changes in suicidal thoughts using the Harkavy-Asnis Suicide Scale at the start, and then one and two months later. The study is currently unclear on its recruitment status and plans to enroll 184 participants.

Study design: This is an interventional study comparing different sequences of behavioral therapies. Participants will be randomly assigned to receive different treatment combinations.
What's involved: You will have at least one 120-minute session, and potentially up to eight sessions. Caregivers will have at least one session and up to four sessions. You will also have assessments at the beginning, 1 month, and 2 months.
Compensation: Not stated in the trial record.
Follow-up: You will be followed for two months after the start of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

Swift Outpatient Alternatives for Rapid Stabilization

Recruiting

NAAges 13–21InterventionalTreatment

University of Washington

~184 participants

Updated 2025-03-27 on ClinicalTrials.gov

What's tested:CAMS Single Session ConsultationDriver Focused Skills TrainingCaregiver Skills TrainingLethal Means Safety

At a glance

Recruiting sites

1 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Harkavy-Asnis Suicide Scale

Measured over baseline, 1, and 2 month follow up

Conditions

Suicidal Ideation

Suicide Attempt

NCT05996172

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

Seattle Children's
Seattle, Washingtonstudy coordinator listed
Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

Molly Adrian, Ph.D. · PRINCIPAL_INVESTIGATOR · University of Washington

Who to contact

Molly Adrian

[email protected]

206-987-7183

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

Acute suicidal thoughts or past month suicide attempt as reported on positive responses to the Ask Suicide Screening Questionnaire (ASQ),

Exclusion

urgent medical care secondary to self-injurious behavior, psychosis, eating disorder that requires full or partial inpatient care, or

intellectual disability warranting a different treatment pathway;

limited English, Spanish, Vietnamese, or Chinese proficiency that would interfere with ability to complete study assessments;

unwillingness to participate in psychotherapy,

caregiver unwilling or ineligible to participate;

and previous enrollment in SOARS program or other P50 project as to not confuse longitudinal follow-up.

What this trial measures

Harkavy-Asnis Suicide Scalebaseline, 1, and 2 month follow up
This measure assesses the frequency of suicidal ideation on a 5-point Likert scale, with 0 indicating "never" and 4 indicating "most or all of the time". Higher scores reflect higher severity and frequency of suicidal ideation.

Trialytics